A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
CAR-T 2.0: off-the-shelf cells vs CAR-NK
CAR-T 2.0 refers to improvements over first-generation CAR-T therapies, which are autologous (patient-derived), personalized, and require long manufacturing timelines. Next-gen CAR-T aims to: Two main approaches: allogeneic (“off-the-shelf”) CAR-T and CAR-NK cells. 1. Allogeneic (“Off-the-Shelf”)…
-
In Vivo Gene Delivery
In vivo gene delivery refers to introducing genetic material directly into a living organism’s cells, rather than manipulating cells outside the body (ex vivo), to achieve therapeutic gene expression in target tissues for disease treatment,…
-
Base Editing vs Prime Editing vs Epigenetic Editing
1. Base Editing Core mechanism: Key outcome: 2. Prime Editing Core mechanism: Key outcome: 3. Epigenetic Editing Core mechanism: Key outcome: Summary Feature Base Editing Prime Editing Epigenetic Editing DNA Break No No (single-strand nick)…
BioTech IP Review 